MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 153 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $40,000 | -97.7% | 4,694 | -96.6% | 0.00% | -100.0% |
| Q2 2015 | $1,710,000 | -4.0% | 138,297 | -7.8% | 0.00% | 0.0% |
| Q1 2015 | $1,782,000 | -29.6% | 150,049 | -34.2% | 0.00% | -25.0% |
| Q4 2014 | $2,530,000 | +46.6% | 228,103 | +16.0% | 0.00% | +33.3% |
| Q3 2014 | $1,726,000 | +150.9% | 196,622 | +69.0% | 0.00% | +200.0% |
| Q2 2014 | $688,000 | +34300.0% | 116,322 | +23883.9% | 0.00% | – |
| Q3 2013 | $2,000 | +100.0% | 485 | +385.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
| KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
| Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
| GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
| Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
| Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
| STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
| Birchview Capital, LP | 44,000 | $136,000 | 0.08% |